Adcirca is a prescription medication containing tadalafil, a phosphodiesterase-5 (PDE5) inhibitor. It primarily treats pulmonary arterial hypertension (PAH), a condition where blood pressure in the arteries leading to the lungs is abnormally high.
Adcirca works by relaxing and widening blood vessels in the lungs. This improves blood flow, reducing strain on the heart and lowering blood pressure in the pulmonary arteries. The increased blood flow delivers more oxygen to the body.
- Mechanism of Action: Tadalafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). Increased cGMP levels cause blood vessel relaxation. Dosage: Your doctor will determine the appropriate dose, typically starting with 20mg once daily. Dosage adjustments may occur based on your response to treatment and any side effects. Administration: Adcirca is usually taken orally, with or without food.
Remember to discuss potential side effects and drug interactions with your healthcare provider before starting Adcirca. They can monitor your progress and adjust the treatment plan accordingly. Adcirca is not suitable for everyone, so a thorough medical evaluation is necessary.
Consult your physician before starting any new medication, including Adcirca. Strictly follow your doctor’s prescribed dosage and instructions. Report any unusual side effects to your healthcare provider immediately.
This information provides a general overview and should not replace professional medical advice. Always consult your doctor or pharmacist for personalized guidance on Adcirca or any other medication.
